CrestPoint Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $890K | Sell |
9,200
-100
| -1% | -$9.67K | 0.49% | 74 |
|
|
2017
Q3 | $826K | Buy |
9,300
+1,300
| +16% | +$115K | 0.37% | 94 |
|
|
2017
Q2 | $580K | Buy |
8,000
+1,000
| +14% | +$72.5K | 0.27% | 127 |
|
|
2017
Q1 | $456K | Buy |
7,000
+1,100
| +19% | +$71.7K | 0.22% | 144 |
|
|
2016
Q4 | $369K | Sell |
5,900
-600
| -9% | -$37.5K | 0.18% | 162 |
|
|
2016
Q3 | $410K | Sell |
6,500
-100
| -2% | -$6.31K | 0.21% | 151 |
|
|
2016
Q2 | $409K | Sell |
6,600
-700
| -10% | -$43.4K | 0.22% | 147 |
|
|
2016
Q1 | $417K | Buy |
7,300
+1,100
| +18% | +$62.8K | 0.23% | 141 |
|
|
2015
Q4 | $367K | Buy |
+6,200
| New | +$367K | 0.21% | 135 |
|